CONTENTS:
• Epidemiology of drug use among biracial/ethnic youth and young adults: Results from a U.S. population-based survey. Clark T.T., Nguyen A.B., Kropko J., p. 99-111.
• Prescription drug misuse and risk behaviors among young injection drug users. Johnson K.M., Fibbi M., Langer D., Silva K., Lankenau S.E., p. 112-121.
• Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders. Choi S., Adams S.M., MacMaster S.A., Seiters J., p. 122-131.
• Poly-drug and marijuana use among adults who primarily used methamphetamine. Herbeck D.M., Brecht M.-L., Lovinger K., Raihan A., Christou D., Sheaff P., p. 132-140.
• From 32 ounces to zero: A medical geographic study of dispensing a cultivated batch of "plum" cannabis flowers to medical marijuana patients in Washington State. Aggarwal S.K., Carter G.T., Zumbrunnen C., Morrill R., Sullivan M., Mayer J.D., p. 141-155.
• Tentative evidence for striatal hyperactivity in adolescent cannabis-using boys: A cross-sectional multicenter fMRI study. Jager G., Block R.I., Luijten M., Ramsey N.F., p. 156-167.
• Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a reversal design: a case study. Harrison R., Rucklidge J.J., Blampied N., p. 168-178.
• A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. dos Santos R.G., p. 179-188.
• Peak experiences of psilocybin users and non-users. Cummins C., Lyke J., p. 189-194.
• Assessment of tear amount in subjects under the effect of (inhaled) cocaine. da Silva C.M.L.R., de Sousa R.A.R.C., Baptista A.M.G., p. 195-198.